Communications medicine · 2026
Understanding the spatial determinants of the Oxford Classic prognostic signature for high-grade serous ovarian cancer.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Stihi Alexandru, Yau Christopher
Аннотация
BACKGROUND: The Oxford Classic (OxC) prognostic signature classifies high-grade serous ovarian cancer (HGSOC) into five transcriptional programs, with epithelial-to-mesenchymal transition (EMT) marking poor prognosis. While successful in bulk transcriptomics, the spatial organisation of these programs within the tumour microenvironment remains unexplored.
METHODS: We developed the Signature-guided Zero-inflated Beta Variational Autoencoder (Sig-ZIB-VAE), a deep learning deconvolution method tailored for spatial transcriptomics data, and applied it to a large-scale HGSOC cohort comprising 94 tumours to quantify spatial cellular organisation. Prognostic significance was assessed using penalised Cox proportional hazards regression integrating clinical, molecular, and spatial features.
RESULTS: Here we show that EMT cells form dense homotypic clusters broadly depleted from stromal and immune neighbourhoods, yet maintain selective monocyte co-localisation at cluster boundaries. EMT-high tumours display enhanced spatial reorganisation characterised by increased clustering and connectivity, forming locally concentrated mesenchymal-rich domains. Survival analysis confirms EMT-high status as an adverse prognostic factor.
CONCLUSIONS: Critically, spatial metrics of immune cell organisation-particularly monocyte connectivity and clustering-provide substantially stronger prognostic discrimination than EMT proportion alone, demonstrating that tumour microenvironment architecture supersedes cellular composition in determining clinical outcomes in HGSOC.
METHODS: We developed the Signature-guided Zero-inflated Beta Variational Autoencoder (Sig-ZIB-VAE), a deep learning deconvolution method tailored for spatial transcriptomics data, and applied it to a large-scale HGSOC cohort comprising 94 tumours to quantify spatial cellular organisation. Prognostic significance was assessed using penalised Cox proportional hazards regression integrating clinical, molecular, and spatial features.
RESULTS: Here we show that EMT cells form dense homotypic clusters broadly depleted from stromal and immune neighbourhoods, yet maintain selective monocyte co-localisation at cluster boundaries. EMT-high tumours display enhanced spatial reorganisation characterised by increased clustering and connectivity, forming locally concentrated mesenchymal-rich domains. Survival analysis confirms EMT-high status as an adverse prognostic factor.
CONCLUSIONS: Critically, spatial metrics of immune cell organisation-particularly monocyte connectivity and clustering-provide substantially stronger prognostic discrimination than EMT proportion alone, demonstrating that tumour microenvironment architecture supersedes cellular composition in determining clinical outcomes in HGSOC.